Thierry van de Wetering
Overview
Explore the profile of Thierry van de Wetering including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
314
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rudnicka H, Masojc B, van de Wetering T, Debniak T, Cybulski C, Gronwald J, et al.
Cancer Epidemiol
. 2014 Jun;
38(4):382-5.
PMID: 24947589
Mutation in the BRCA1 gene increases the risk of the person developing breast and/or ovarian cancer. The prevalence and spectrum of large genomic rearrangements (LGRs) varies considerably among different tested...
12.
Mirecka A, Paszkowska-Szczur K, Scott R, Gorski B, van de Wetering T, Wokolorczyk D, et al.
Gene
. 2014 Jun;
546(2):156-61.
PMID: 24933002
The genetic basis of prostate cancer (PC) is complex and appears to involve multiple susceptibility genes. A number of studies have evaluated a possible correlation between several NER gene polymorphisms...
13.
Antczak A, Kluzniak W, Wokolorczyk D, Kashyap A, Jakubowska A, Gronwald J, et al.
Gene
. 2013 Oct;
532(2):173-6.
PMID: 24096176
Background: Germline mutations of BRCA2 and NBS1 genes cause inherited recessive chromosomal instability syndromes and predispose to prostate cancer of poor prognosis. Mutations of the BLM gene cause another chromosomal...
14.
Kashyap A, Kluzniak W, Wokolorczyk D, Golab A, Sikorski A, Slojewski M, et al.
Int J Cancer
. 2013 Sep;
134(5):1139-46.
PMID: 24037955
Several single nucleotide polymorphisms (SNPs) have been associated with an elevated risk of prostate cancer risk. It is not established if they are useful in predicting the presence of prostate...
15.
Masojc B, Gorski B, van de Wetering T, Debniak T, Cybulski C, Jakubowska A, et al.
Hum Mutat
. 2013 Mar;
34(4):636-43.
PMID: 23520118
Multiple genotyping techniques were developed on the basis of real-time PCR. In this article, we present a genotyping technique extending the induced Förster resonance energy transfer (iFRET) mechanism in conjunction...
16.
Debniak T, Cybulski C, Kurzawski G, Gorski B, Huzarski T, Byrski T, et al.
Hered Cancer Clin Pract
. 2010 Mar;
4(1):52-5.
PMID: 20223005
No abstract available.
17.
Wokolorczyk D, Gliniewicz B, Stojewski M, Sikorski A, Zlowocka E, Debniak T, et al.
Eur J Cancer Prev
. 2009 Dec;
19(2):167-71.
PMID: 19952762
Several recent association studies implicate three neighbouring regions of chromosome 8q24 as the site of prostate cancer susceptibility loci. One region contains both a microsatellite marker DG8S737 and a single...
18.
Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T, et al.
Cancer Res
. 2008 Dec;
68(23):9982-6.
PMID: 19047180
Several genome-wide searches for common cancers have lead to the identification of a small number of loci that harbor low-risk cancer susceptibility markers. One marker, rs6983267 on chromosome 8q24, has...
19.
Debniak T, van de Wetering T, Scott R, Nagay L, Cybulski C, Gorski B, et al.
Eur J Cancer Prev
. 2008 Aug;
17(5):389-91.
PMID: 18714178
In this report the contribution of CDKN2A/ARF germline mutations to early-onset cancers of the breast, pancreas and malignant melanoma was examined. We screened 66 women with breast cancer diagnosed at...
20.
Zlowocka E, Cybulski C, Gorski B, Debniak T, Slojewski M, Wokolorczyk D, et al.
Int J Cancer
. 2007 Oct;
122(3):583-6.
PMID: 17918154
Germline mutations in CHEK2 have been associated with a range of cancer types but little is known about disease risks conveyed by CHEK2 mutations outside of the context of breast...